Company profile for Domainex

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research. Our expertise and commitme...
Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Chesterford Research Park Little Chesterford Saffron Walden Essex, CB10 1XL UK
Telephone
Telephone
+44 (0) 1223 743170
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20241104544171/en

BUSINESSWIRE
04 Nov 2024

https://www.pharmatimes.com/news/amphista_partners_with_domainex_to_advance_drug_portfolio_1456393

PHARMATIMES
06 Oct 2022

https://www.pharmiweb.com/press-release/2022-09-14/anti-inflammatory-drug-candidate-dmxd-011-shows-efficacy-in-ex-vivo-human-studies

PHARMIWEB
14 Sep 2022

https://www.pharmatimes.com/news/parkinsons_uk_and_domainex_join_forces_to_develop_neuroinflammation_therapies_1387165

PHARMATIMES
03 Feb 2022

https://www.pharmtech.com/view/expansion-of-apeiron-biologics-and-domainex-partnership-will-advance-cancer-drug-discovery

PHARMTECH
25 Nov 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty